Header Logo

Connection

STEPHEN PAPPAS to Humans

Back to Details
This is a "connection" page, showing publications STEPHEN PAPPAS has written about Humans.
STEPHEN PAPPAS
Connection Strength
0.133
Humans
  1. Hepatitis B and Health Care Workers. Clin Liver Dis. 2021 11; 25(4):859-874.
    View in: PubMed
    Score: 0.021
  2. Alcohol and the Law. Clin Liver Dis. 2019 02; 23(1):25-38.
    View in: PubMed
    Score: 0.017
  3. Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 07; 16(7):1174.
    View in: PubMed
    Score: 0.016
  4. Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope". Aliment Pharmacol Ther. 2017 11; 46(10):1011-1012.
    View in: PubMed
    Score: 0.016
  5. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol. 2018 02; 16(2):162-177.e1.
    View in: PubMed
    Score: 0.015
  6. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 2024 04 01; 30(4):347-355.
    View in: PubMed
    Score: 0.006
  7. The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome. Kidney360. 2023 08 01; 4(8):1030-1038.
    View in: PubMed
    Score: 0.006
  8. Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3455-3457.e3.
    View in: PubMed
    Score: 0.006
  9. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022 10; 56(8):1284-1293.
    View in: PubMed
    Score: 0.006
  10. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021 03 04; 384(9):818-828.
    View in: PubMed
    Score: 0.005
  11. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome. Nephrol Dial Transplant. 2020 09 01; 35(9):1554-1561.
    View in: PubMed
    Score: 0.005
  12. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017 Jun; 45(11):1390-1402.
    View in: PubMed
    Score: 0.004
  13. Terlipressin Improves Renal Function and Reverses Hepatorenal?Syndrome in Patients With Systemic Inflammatory?Response?Syndrome. Clin Gastroenterol Hepatol. 2017 02; 15(2):266-272.e1.
    View in: PubMed
    Score: 0.004
  14. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Gastroenterology. 2016 Jun; 150(7):1579-1589.e2.
    View in: PubMed
    Score: 0.004
  15. Curbside Consultations: The Good, the Bad, and the Ugly. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):2-4.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.